Skip to main content
. 2014 Aug 7;13:187. doi: 10.1186/1476-4598-13-187

Table 1.

Clinicopathological features and correlation with Pfn1 expression in pancreatic ductal adenocarcinoma

Characteristics No. Pfn1-Low Score(-/+)(n = 35) Pfn1-High Score(++/+++)(n = 37) P value
Age (y) 0.842a
  <60 30 15 (20.8%) 15 (20.8%)
  ≥60 42 20 (27.8%) 22 (30.6%)
Gender 0.118a
  Female 25 9 (12.5%) 16 (22.2%)
  Male 47 26 (36.1%) 21 (29.2%)
Tumor size (cm) 0.568a
  <4.0 47 24 (33.3%) 23 (32.0%)
  ≥4.0 25 11 (15.3%) 14 (19.4%)
Tumor differentiation 0.001a
  Well 13 3 (4.2%) 10 (13.9%)
  Moderate 43 18 (25.0%) 25 (34.7%)
  Poor 16 14 (19.4%) 2 (2.8%)
Lymph node status (stage) 0.101a
  Negative (IIA) 44 18 (25.0%) 26 (36.1%)
  Positive (IIB) 28 17 (23.6%) 11 (15.3%)
Vessel Infiltration 0.068a
  Negative 56 24 (33.3%) 32 (44.4%)
  Positive 16 11 (15.3%) 5 (7.0%)
Nerve Infiltration 0.683a
  Negative 17 9 (12.5%) 8 (11.1%)
  Positive 55 26 (36.1%) 29 (40.3%)
Median survival (in months) 14.2 20.9 0.008b

aP values were derived using Pearson chi-square tests.

bP values were derived using a log rank test.

All statistical tests are two sided.

Abbreviations: Pfn1 Profilin-1.